Canlyniadau Chwilio - Adriaan J. van der Meer

  • Dangos 1 - 17 canlyniadau o 17
Mireinio'r Canlyniadau
  1. 1
    Reversion of disease manifestations after HCV eradication

    Reversion of disease manifestations after HCV eradication gan Adriaan J. van der Meer, Marina Berenguer

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Is there sufficient evidence to recommend antiviral therapy in hepatitis C?

    Is there sufficient evidence to recommend antiviral therapy in hepatitis C? gan Adriaan J. van der Meer, Heiner Wedemeyer, Jordan J. Feld, Bettina E. Hansen, Michael P. Manns, Stefan Zeuzem, Harry L.A. Janssen

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

    Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis gan Maren H. Harms, Adriaan J. van der Meer, Willem J. Lammers, Christophe Corpechot, Douglas Thorburn, Harry L.A. Janssen, Keith D. Lindor, Palak Trivedi, Gideon M. Hirschfield, Albert Parés, Annarosa Floreani, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Frederik Nevens, Cyriel Y. Ponsioen, Andrew L. Mason, Kris V. Kowdley, Bettina E. Hansen, Henk R. van Buuren, Adriaan J. van der Meer

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Miravirsen dosing in chronic hepatitis C patients results in decreased micro<scp>RNA</scp>‐122 levels without affecting other micro<scp>RNA</scp>s in plasma

    Miravirsen dosing in chronic hepatitis C patients results in decreased micro<scp>RNA</scp>‐122 levels without affecting other micro<scp>RNA</scp>s in plasma gan Meike H. van der Ree, Adriaan J. van der Meer, Ad C. van Nuenen, Joep de Bruijne, Søren Ottosen, Harry L.A. Janssen, Neeltje A. Kootstra, H. W. Reesink

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis

    Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis gan Hooman Farhang Zangneh, William Wong, Beate Sander, Chaim M. Bell, Khalid Mumtaz, Matthew Kowgier, Adriaan J. van der Meer, Sean P. Cleary, Harry L.A. Janssen, Kelvin Chan, Jordan J. Feld

    Cyhoeddwyd 2018
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity

    Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity gan Lisette Krassenburg, Raoel Maan, Alnoor Ramji, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer, Robert J. de Knegt, Bettina E. Hansen, Harry L.A. Janssen, Robert A. de Man, Jordan J. Feld, Adriaan J. van der Meer

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis

    Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis gan Raoel Maan, Marjolein van Tilborg, Katja Deterding, Alnoor Ramji, Adriaan J. van der Meer, Florence Wong, Scott Fung, Morris Sherman, Michael P. Manns, Markus Cornberg, Bettina E. Hansen, Heiner Wedemeyer, Harry L.A. Janssen, Robert J. de Knegt, Jordan J. Feld

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Treatment of HCV Infection by Targeting MicroRNA

    Treatment of HCV Infection by Targeting MicroRNA gan Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz, Stefan Zeuzem, M. Rodríguez‐Torres, Keyur Patel, Adriaan J. van der Meer, Amy K. Patick, Alice P. Chen, Yi Zhou, Robert Persson, Barney D. King, Sakari Kauppinen, Arthur A. Levin, Michael R. Hodges

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis

    Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis gan Adriaan J. van der Meer, Raoel Maan, Bart J. Veldt, Jordan J. Feld, Heiner Wedemeyer, Jean‐François Dufour, Frank Lammert, Andrés Duarte‐Rojo, Michael P. Manns, Stefan Zeuzem, Wolf Peter Hofmann, Robert J. de Knegt, Bettina E. Hansen, Harry L.A. Janssen

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B

    Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B gan Lesley A. Patmore, Warshan K. Katwaroe, Daniël P. C. van der Spek, Hannah Choi, Keyur P. Patel, Sylvia Brakenhoff, Adriaan J. van der Meer, Willem Pieter Brouwer, Laurens A. van Kleef, Robert J. de Knegt, Bettina E. Hansen, Rob A. de Man, Jordan J. Feld, Harry L.A. Janssen, Milan J. Sonneveld

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

    Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis gan Maren H. Harms, Henk R. van Buuren, Christophe Corpechot, Douglas Thorburn, Harry L.A. Janssen, Keith D. Lindor, Gideon M. Hirschfield, Albert Parés, Annarosa Floreani, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Frederik Nevens, Cyriel Y. Ponsioen, Andrew L. Mason, Kris V. Kowdley, Willem J. Lammers, Bettina E. Hansen, Adriaan J. van der Meer

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

    Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase gan Carla Fiorella Murillo Perez, Maren H. Harms, Keith D. Lindor, Henk R. van Buuren, Gideon M. Hirschfield, Christophe Corpechot, Adriaan J. van der Meer, Jordan J. Feld, Aliya Gulamhusein, Willem J. Lammers, Cyriel Y. Ponsioen, Marco Carbone, Andrew L. Mason, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Annarosa Floreani, Ana Lleó, Frederik Nevens, Kris V. Kowdley, Tony Bruns, George N. Dalekos, Nikolaos Gatselis, Douglas Thorburn, Palak Trivedi, Xavier Verhelst, Albert Parés, Harry L.A. Janssen, Bettina E. Hansen

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation

    Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation gan Aldo J. Montaño‐Loza, Ellina Lytvyak, Gideon M. Hirschfield, Bettina E. Hansen, Maryam Ebadi, Thierry Berney, Christian Toso, Giulia Magini, Alejandra Villamil, Frederik Nevens, Natalie Van den Ende, Albert Pares, Pablo Ruiz, Débora Terrabuio, Palak J Trivedi, Nadir Abbas, Maria Francesca Donato, Lei Yu, Charles Landis, Jérôme Dumortier, Jessica Dyson, Adriaan J. van der Meer, Rozanne de Veer, Mark Pedersen, Marlyn J. Mayo, Michael P. Manns, Richard Taubert, Theresa A. Kirchner, L Belli, Chiara Mazzarelli, Guido Stirnimann, Annarosa Floreani, Nora Cazzagon, Francesco Paolo Russo, Patrizia Burra, Udi Zigmound, Inbal Houri, Marco Carbone, Giacomo Mulinacci, Stefano Fagiuoli, Daniel S. Pratt, Alan Bonder, Thomas D Schiano, Brandy Haydel, Ansgar W. Lohse, Christoph Schramm, Darius F. Rüther, Stefania Casu, Xavier Verhelst, Benedetta Terziroli Beretta-Piccoli, Mercedes Robles‐Díaz, Andrew L Mason, Christophe Corpechot

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2

    Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2 gan V A Saraswat, Suzanne Norris, Robert J. de Knegt, J.F. Sánchez-Ávila, Mark Sonderup, Eli Zuckerman, Perttu Arkkila, Catherine Stedman, Subrat Kumar Acharya, Inka Aho, Anil C. Anand, Monique Andersson, Vic Arendt, Oidov Baatarkhuu, Kieron Barclay, Ziv Ben‐Ari, Colm Bergin, Fernando Bessone, Sarah Blach, Н. П. Блохина, Cheryl Brunton, G. Choudhuri, Vladimir Chulanov, L. Cisneros, Esther Croes, Dahgwahdorj Yagaanbuyant, Olav Dalgård, Jorge Daruich, Naranjargal Dashdorj, D. Davaadorj, M. de Vree, Chris Estes, Robert Flisiak, Adrián Gadano, Edward Gane, Waldemar Halota, Angelos Hatzakis, C. R. Henderson, Patrick Hoffmann, John Hornell, D. Houlihan, S. Hrušovský, Peter Jarčuška, David Kershenobich, K. Kostrzewska, Pavol Kristián, Moshe Leshno, Yoav Lurie, Adam Mahomed, N. Mamonova, Nahúm Méndez‐Sánchez, Joël Mossong, E. Nurmukhametova, Pagbajabyn Nymadawa, Marián Oltman, Janchiv Oyunbileg, Ts. Oyunsuren, George Papatheodoridis, Nikolay Pimenov, Nishi Prabdial‐Sing, Maria Prins, P. Puri, Sarah Radke, Aza Rakhmanova, Homie Razavi, Kathryn Razavi‐Shearer, Hendrik W. Reesink, Ezequiel Ridruejo, Rifaat Safadi, Olga Sagalova, Ruvjir Sanduijav, Ivan Schréter, Carole Seguin‐Devaux, Samir R. Shah, I V Shestakova, A. Shevaldin, Oren Shibolet, С. С. Соколов, Kyriakos Souliotis, C Wendy Spearman, Thérèse Staub, Е.А. Strebkova, Daniel Struck, Krzysztof Tomasiewicz, L. Undram, Adriaan J. van der Meer, Daniela van Santen, Irene Veldhuijzen, F. G. Villamil, Sophie B. Willemse, Freke Zuure, M. O. Silva, Vana Sypsa, E. Gower

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2

    The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2 gan Angelos Hatzakis, Vladimir Chulanov, Adrián Gadano, Colm Bergin, Ziv Ben‐Ari, Joël Mossong, Ivan Schréter, Oidov Baatarkhuu, Subrat Kumar Acharya, Inka Aho, Anil C. Anand, Monique Andersson, Vic Arendt, Perttu Arkkila, Kieron Barclay, Fernando Bessone, Sarah Blach, Н. П. Блохина, Cheryl Brunton, G. Choudhuri, L. Cisneros, Esther Croes, Dahgwahdorj Yagaanbuyant, Olav Dalgård, Jorge Daruich, Naranjargal Dashdorj, D. Davaadorj, Robert J. de Knegt, M. de Vree, Chris Estes, Robert Flisiak, Edward Gane, E. Gower, Waldemar Halota, C. R. Henderson, Patrick Hoffmann, John Hornell, D. Houlihan, S. Hrušovský, Peter Jarčuška, David Kershenobich, K. Kostrzewska, Pavol Kristián, Moshe Leshno, Yoav Lurie, Adam Mahomed, N. Mamonova, Nahúm Méndez‐Sánchez, Suzanne Norris, E. Nurmukhametova, Pagbajabyn Nymadawa, Marián Oltman, Janchiv Oyunbileg, Ts. Oyunsuren, George Papatheodoridis, Nikolay Pimenov, Nishi Prabdial‐Sing, Maria Prins, Sarah Radke, Aza Rakhmanova, Kathryn Razavi‐Shearer, H. W. Reesink, Ezequiel Ridruejo, Rifaat Safadi, Olga Sagalova, J.F. Sánchez-Ávila, Ruvjir Sanduijav, V A Saraswat, Carole Seguin‐Devaux, Samir R. Shah, I V Shestakova, A. Shevaldin, Oren Shibolet, M. O. Silva, С. С. Соколов, Mark Sonderup, Kyriakos Souliotis, C Wendy Spearman, Thérèse Staub, Catherine Stedman, Е.А. Strebkova, Daniel Struck, Vana Sypsa, Krzysztof Tomasiewicz, L. Undram, Adriaan J. van der Meer, Daniela van Santen, Irene Veldhuijzen, F. G. Villamil, Sophie B. Willemse, Eli Zuckerman, Freke Zuure, P. Puri, Homie Razavi

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Strategies to manage hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infection disease burden – volume 2

    Strategies to manage hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infection disease burden – volume 2 gan Edward Gane, David Kershenobich, Carole Seguin‐Devaux, Pavol Kristián, Inka Aho, Olav Dalgård, I V Shestakova, Pagbajabyn Nymadawa, Sarah Blach, Subrat Kumar Acharya, Anil C. Anand, Monique Andersson, Vic Arendt, Perttu Arkkila, Oidov Baatarkhuu, Kieron Barclay, Ziv Ben‐Ari, Colm Bergin, Fernando Bessone, Н. П. Блохина, Cheryl Brunton, G. Choudhuri, Vladimir Chulanov, L. Cisneros, Esther Croes, Dahgwahdorj Yagaanbuyant, Jorge Daruich, Naranjargal Dashdorj, D. Davaadorj, Robert J. de Knegt, M. de Vree, Adrián Gadano, E. Gower, Waldemar Halota, Angelos Hatzakis, C. R. Henderson, Patrick Hoffmann, John Hornell, D. Houlihan, S. Hrušovský, Peter Jarčuška, K. Kostrzewska, Moshe Leshno, Yoav Lurie, Adam Mahomed, N. Mamonova, Nahúm Méndez‐Sánchez, Joël Mossong, Suzanne Norris, E. Nurmukhametova, Marián Oltman, Janchiv Oyunbileg, Ts. Oyunsuren, George Papatheodoridis, Nikolay Pimenov, Maria Prins, P. Puri, Sarah Radke, Aza Rakhmanova, Homie Razavi, Kathryn Razavi‐Shearer, H. W. Reesink, Ezequiel Ridruejo, Rifaat Safadi, Olga Sagalova, J.F. Sánchez-Ávila, Ruvjir Sanduijav, V A Saraswat, Ivan Schréter, Samir R. Shah, A. Shevaldin, Oren Shibolet, M. O. Silva, С. С. Соколов, Mark Sonderup, Kyriakos Souliotis, C Wendy Spearman, Thérèse Staub, Catherine Stedman, Е.А. Strebkova, Daniel Struck, Vana Sypsa, Krzysztof Tomasiewicz, L. Undram, Adriaan J. van der Meer, Daniela van Santen, Irene Veldhuijzen, F. G. Villamil, Sophie B. Willemse, Eli Zuckerman, Freke Zuure, Nishi Prabdial‐Sing, Robert Flisiak, Chris Estes

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

    Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls gan Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Dorcas Kareithi, Femi Adekunle, Tracy J. Mayne, Elizabeth Smoot Malecha, Erik C. Ness, Adriaan J. van der Meer, Willem J. Lammers, Palak Trivedi, Pier Maria Battezzati, Frederik Nevens, Kris V. Kowdley, Tony Bruns, Nora Cazzagon, Annarosa Floreani, Andrew L. Mason, Albert Parés, María‐Carlota Londoño, Pietro Invernizzi, Marco Carbone, Ana Lleó, Marlyn J. Mayo, George Ν. Dalekos, Nikolaos Gatselis, Douglas Thorburn, Xavier Verhelst, Aliya Gulamhusein, Harry L.A. Janssen, Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher G. Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard J. Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James L. Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, G. W. G. Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash C. Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: